Compound Summary
Compound Name: | Lidocaine N-ethyl bromide |
Compound CID: | 9884487 |
Synonyms: | Lidocaine N-ethyl bromide QX 314 bromide QX-314 21306-56-9 24003-58-5 More... |
Iupac Name: | [2-(2,6-dimethylanilino)-2-oxoethyl]-triethylazanium;bromide |
InChI: | InChI=1S/C16H26N2O.BrH/c1-6-18(7-2,8-3)12-15(19)17-16-13(4)10-9-11-14(16)5;/h9-11H,6-8,12H2,1-5H3;1H |
InChIKey: | DLHMKHREUTXMCH-UHFFFAOYSA-N |
Canonical Smiles: | CC[N+](CC)(CC)CC(=O)NC1=C(C=CC=C1C)C.[Br-] |
Isomeric Smiles: | CC[N+](CC)(CC)CC(=O)NC1=C(C=CC=C1C)C.[Br-] |
Molecular Weight: | 343.3 |
Molecular Formula: | C16H27BrN2O |
Molecular Weight: | 343.3 |
Molecular Formula: | C16H27BrN2O |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 20 |
Complexity: | 268 |
Lidocaine N-ethyl bromide | Lidocaine N-ethyl bromide |
---|---|
Lidocaine N-ethyl bromide |
QX 314 bromide |
QX-314 |
21306-56-9 |
24003-58-5 |
QX-314 (bromide) |
Lidocaine N-ethyl bromide quaternary salt |
QX-314 Br |
N-(2,6-Dimethylphenylcarbamoylmethyl)triethylammonium bromide |
UNII-3OYF1S84EN |
3OYF1S84EN |
2-(2,6-dimethylanilino)-2-oxoethyl-triethylazanium;bromide |
ETHANAMINIUM,2-(2,6-DIMETHYLPHENYL)AMINO-N,N,N-TRIETHYL-2-OXO- |
SR-01000075323 |
Ethanaminium, 2-((2,6-dimethylphenyl)amino)-N,N,N-triethyl-2-oxo-, bromide (1:1) |
Ethanaminium, 2-(2,6-dimethylphenyl)amino-N,N,N-triethyl-2-oxo-, bromide (1:1) |
QX-314 BROMIDE |
MLS000859919 |
SCHEMBL746069 |
QX-314.Br |
CHEMBL1255750 |
DTXSID001018052 |
HMS1361J13 |
HMS2235P07 |
HMS3262G19 |
HMS3267O03 |
HMS3370A05 |
HMS3402J13 |
HMS3411P16 |
HMS3675P16 |
BCP33056 |
ZAA00358 |
Tox21_500679 |
MFCD00083182 |
AKOS024456333 |
CCG-221983 |
LP00679 |
MB00591 |
NCGC00094039-01 |
NCGC00094039-02 |
NCGC00261364-01 |
SMR000326780 |
QX-314;QX 314 bromide;QX-314.Br |
HY-101350 |
B6547 |
CS-0021195 |
EU-0100679 |
FT-0748930 |
L 5783 |
J-013978 |
QX-314 - CAS 21306-56-9 |
SR-01000075323-1 |
SR-01000075323-3 |
Lidocaine N-ethyl bromide, analytical standard, for drug analysis |
2-(2,6-DIMETHYLPHENYLAMINO)-N,N,N-TRIETHYL-2-OXOETHANAMINIUM BROMIDE |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | 2.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 2.000000000000000 | 1 | 1 |